We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · October 14, 2014

Sunitinib-Induced Hypertension, Neutropenia, and Thrombocytopenia Predict Good Prognosis in Metastatic RCC

BJU International

 

Additional Info

BJU International
Sunitinib-Induced Hypertension, Neutropenia and Thrombocytopenia as Predictors of Good Prognosis in Metastatic Renal Cell Carcinoma Patients
BJU Int 2014 Sep 23;[EPub Ahead of Print], J Rautiola, F Donskov, K Peltola, H Joensuu, P Bono

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading